Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT06370130

Different Dose of Esketamine Inhibiting Response to Laryngeal Mask Airway Insertion

Determation of Median Effective Dose of Propofol Combined With Different Dose of Esketamine Inhibiting Response to Laryngeal Mask Airway Insertion in Female Patients

Sponsor: Aerospace Center Hospital

Conditions Anesthesia

Interventions Esketamine 0.2mg/kg Esketamine 0.3mg/kg

Updated 3 times since 2024 Last updated: Apr 15, 2024 Started: May 1, 2022 Primary completion: Dec 20, 2022 Completion: Mar 10, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06370130, this EARLY_PHASE1 trial focuses on Anesthesia and remains completed. Sponsored by Aerospace Center Hospital, it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
May 2024 — Jul 2024 [monthly]

Completed EARLY_PHASE1

First recorded

May 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aerospace Center Hospital

Data source: Aerospace Center Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China